Johnson & Johnson Q3 Profit Decreases
Key Takeaways Johnson & Johnson reports earnings before the opening bell Tuesday, with revenue and profit projected to ...
Johnson & Johnson expects full-year earnings in the range of $9.88 to $9.98 per share, with revenue in the range of $88.4 billion to $88.8 billion. This story was generated by Automated Insights ( ...
Johnson & Johnson filed an unprecedented third chapter 11 case seeking to end the mass lawsuits linking its cosmetic talc products to cancer, this time with the backing of tens of thousands of ...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Mike Florio and Chris Simms analyze the Lions' offensive showing vs. the Cowboys, discussing Ben Johnson's role in Jared Goff ...
Johnson & Johnson’s hopes to use a bankruptcy ... speak for nearly 12,000 gynecological cancer victims. The healthcare-products company last week filed its third bankruptcy case seeking a ...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Kenvue products will continue to bear the name Johnson & Johnson and the old logo for the time being – presumably until the old stock is ready to be replaced with its new branding, also designed ...
Johnson & Johnson JNJ, via its subsidiary called Red River Talc, for the third time, filed for voluntary bankruptcy to resolve thousands of lawsuits related to its talc products. Red River Talc ...
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results